Skip to main content

Table 1 Characteristics at baseline of the study participants

From: The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

 

All subjects

Anti-Tat Ab-positivea

Anti-Tat Ab-negative

(n = 61)

(n = 20)

(n = 41)

Age (years)

38 (32–42)

38 (32–43)

38 (32–41)

Male (%)

90.2

95.0

87.8

Female (%)

9.8

5.0

12.2

CD4+ (cells/ÎĽl)

544 (463–678)

546 (500–702)

541 (454–640)

CD4+ (%)

29.0 (25.0-34.0)

29.0 (25.0-33.0)

28.5 (25.5-34.5)

Viral load (log10 copies/ml)

4.2 (3.7-4.5)

4.2 (3.7-4.6)

4.2 (3.9-4.4)

Years from diagnosis of HIVb

1.3 (0.9-3.2)

1.0 (0.7-4.0)

1.6 (1.0-2.7)

HAART initiation since HIV+ (years)c

3.6 (2.9-5.0)

3.6 (3.2-5.4)

3.5 (2.6-5.0)

HAART initiation since study entry (months)c

22 (14–19)

30 (28–31)

17 (13–22)

  1. Data are expressed as median with interquartile range (IQR).
  2. aEight individuals became anti-Tat Ab-positive during follow-up; bBased on 52 individuals.
  3. cBased on data from 13 individuals, 4 anti-Tat Ab-positive with low and transient anti-Tat Abs (3 IgM and 1 IgG) and 9 anti-Tat Ab-negative.
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us